Skip to main content
    I

    Inspire Medical Systems Inc (INSP)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $59.07
    -2.03 (-3.32%)

    Market Cap: $1.77B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Inspire Medical Systems Inc (INSP) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Inspire Medical Systems (INSP) trades at 29.1x trailing earnings and 1.9x sales. Its P/S of 1.9x is below its 5-year median of 7.7x. Its forward P/E is 51.5x. The median P/E across 6 similar companies is 27.0x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 43.5% lower over the next year. Its free cash flow yield is 5.7%.

    MultipleValue
    P/E (trailing)29.1x
    Forward P/E51.5x
    Price to sales1.9x
    Price to book2.1x
    EV/EBITDA46.1x
    Price to FCF17.5x
    EV/FCF15.5x
    PEGN/A
    FCF yield5.7%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 87.3% below 15.0x and its P/B is 80.2% below 10.6x.

    MultipleCurrent5-year median10-year median
    P/S1.9x7.7x15.0x
    P/B2.1x8.5x10.6x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 101 to 102 months (10-year).

    Valuation History

    Over the 8 year ends shown, its P/S ranged from 3.0x in 2025 to 42.9x in 2020. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$92.2335.7x3.0x3.4x
    2024$185.38107.2x6.9x8.3x
    2023$203.43N/A9.6x10.7x
    2022$251.88N/A17.7x15.3x
    2021$230.06N/A26.9x27.5x
    2020$188.09N/A42.9x22.1x
    2019$74.21N/A21.6x12.8x
    2018$42.25N/A4.2x5.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About INSP

    What is INSP's forward P/E ratio?

    Inspire Medical Systems has a forward P/E ratio of 51.5x.

    Is INSP stock overvalued?

    GNG's valuation label for INSP is Undervalued. Its P/E of 29.1x compares with a median of 27.0x across 6 similar companies.

    What is INSP's price to sales ratio?

    Inspire Medical Systems has a price to sales ratio of 1.9x.